Position in MEDP
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$5,879,926
-$4,391,529 QoQ
Shares Held
12,245
-33.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Summit Creek Advisors LLC holds $13,155,971 across 2 Diagnostics & Research names. MEDP ranks #2 (44.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
|
225,894 | $7,276,045 | |
| 2 | MEDP |
Medpace Holdings, Inc.
This page
|
12,245 | $5,879,926 |
All Filings in MEDP
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,879,926 | 12,245 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $10,271,455 | 18,288 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $17,595,583 | 34,222 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $15,724,699 | 50,101 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $15,914,568 | 52,232 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $15,883,251 | 47,808 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $15,909,575 | 47,662 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,303,465 | 42,014 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $19,745,152 | 48,856 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $14,884,177 | 48,557 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,580,370 | 23,047 | Shares | Sole | 2023-10-30 | |
| No filing history on record for this holder in this stock. | ||||||